Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome
Tirzepatides glucose-lowering effects may be additive with other medications that affect blood glucose, potentially increasing the risk of hypoglycemia
Approximately four weeks prior to admission, he complained of severe constipation, nausea, and vomiting, and accordingly, the semaglutide dose was reduced to 0.25 mg weekly
Gentle movement actually helps
In this review we describe the available evidence in detail and present a rational practical guidance for the optimum clinical use of this combination in this patient population
Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C